Past event: MASS Medical Affairs Strategic Summit West

Manage Medical Affairs, Communications, Information and Research Collaborations to Strategically Position Your Organization in hte Marketplace

FOUR TRACKS | ONE LOCATION | ALL ACCESS

Medical Affairs Executive Strategy

Medical affairs teams are involved in nearly all aspects of communication in a pharmaceutical/biotechnology/medical device organization. Their scope and authority can vary depending on the size of the business. One of the biggest issues medical affairs teams have faced in recent years has been the need to establish standard operating procedures and quality control measures for social media posts. With Twitter, Facebook and other networks in use by virtually all employees, medical affairs teams need to pinpoint who regulates company posts, what information is released and how posts should be edited.

The Medical Affairs Executive Strategy track will address the management and communication concerns internal teams face as well as how to best improve current processes in order to comply with new regulations and the instant access to information.


MSL Best Practices

The role of the medical science liaison (MSL) has continued to expand. Previously, MSLs served as the link between their respective organizations and key opinion leaders (KOLs). As subject matter experts, MSLs convey product information to educate the KOL, then relay information back to their own organization. While this has not changed, MSLs are now taking on a more hybrid role, encompassing account/relationship management responsibilities in addition to interacting with clinical and business teams. To maintain the expanding list of responsibilities, MSLs need to be continuously trained and assessed for regulatory compliance and other various roles.

Accompanying the growth of the MSL role, data indicates that KOLs and physicians increasingly prefer to work with MSLs instead of sales or account managers.

The MSL Best Practices track will focus on the MSL’s growing duties and on the exchange of MSL training and evaluation techniques in both small and large organizations.


Research Collaboration and Investigator-Initiated Trials

Research collaborations play a vital role in the discovery of new drug indications and the treatment of unmet medical needs. The growing collaboration between industry and academic investigators has led to increased funding and opened the doors to achieving promising clinical outcomes. Medical affairs professionals, MSLs, clinical operations and external research parties all work closely with investigators to achieve successful trials that can lead to new milestones in drug development. This collaboration between medical affairs, MSLs and clinical research teams is the backbone for successfully cultivating and communicating the value of treatments.

Standardization of terms, policies and procedures will help with vendor interactions and pave the way to more efficiently defining the lines of what is truly an investigator-initiated trial and what is a research collaboration.

The Research Collaboration and Investigator-Initiated Trials track covers all aspects of conducting trials — including ways in which investigators can efficiently reach out to industry professionals to foster supportive relationships — and addresses how industry optimizes and standardizes the discussion of clinical research to improve trial support and oversight. It also examines quality measures in detail to ensure compliance throughout the product life cycle.


Medical Information and Call Center Management

Call centers (also referred to as contact centers) are another source of external medical and scientific communication. With the evolution of MSL and medical professionals' roles and responsibilities, companies are looking to streamline their medical information and communication processes. Pharmaceutical organizations have set up call centers where healthcare personnel, physicians and other stakeholders can call a company to learn more about a product, speak to a specialist about pharmaceutical specifics or report an adverse event.

At MASS West, the Medical Information and Call Center Management track will examine the organization of pharmaceutical call centers. During sessions, case studies and panels, key industry leaders will compare the benefits and disadvantages of in-house call centers and outsourced call centers, examine compliant communication strategies with patients, discuss the chain of custody of information in issue management, illustrate the benefits of monitoring externally published information, and strategize medical information communication through multiple mediums.

Speakers

  • Dominick Albano, Vice President, Global Medical Information
  • Harvey Arbit, Pharm.D., Professor
  • Ryan Arnold, Vice President, Head of Medical Affairs
  • Lynn Bass, Director, Medical Science Liaisons (Americas)
  • Christopher Bess, Associate Director, UCB Cares
  • Anisha Bhagat, Pharm.D., Manager, Global Medical Affairs
  • Pauline Bianchi, Senior Director, Medical Affairs— Pulmonology
  • Fernando Blanco, Ph.D., Senior Medical Science Liaison
  • Jeff Braziunas, Ph.D., Sr. Medical Science Liaison, Oncology
  • Matthew Bryant, Pharm.D., Associate Director, Medical Affairs
  • Julio Casoy, M.D., Senior Vice President, Medical Affairs
  • Arthur Chan, Ph.D., MBA, Head, MSL Capabilities, Development and Training
  • Dannis Chang, Pharm.D., Strategic Program Lead - Business Innovations, U.S. Medical Affairs
  • Tammy Coberly, Pharm.D., Executive Director, Medical Science Liaisons
  • Joseph Cosico, Director, Clinical Research Operations
  • Kasmin Delgado, Medical Science Liaison
  • Ramin Farhood, Pharm.D., MBA, Vice President, Head of Global Medical Affairs
  • Vicki L. Fisher, RN, Director, Medical Affairs Operations and Training
  • James Fratantonio, Pharm.D., Manager, Medical Information
  • David Freilich, Senior Medical Science Liaison and Senior Team Trainer
  • Noam Frey, M.D., MBA, Vice President, Medical Affairs
  • Christy Gilchrist, Ph.D., Director of Research
  • Axel Grothey, M.D., Chair
  • Sarah Guadagno, Ph.D., Vice President, Medical Affairs, Communications and Information
  • Deborah Hails, Director, Hematology MSLs, US Medical Affairs
  • Fawn Hangge, Program Manager
  • Diane Hanna, Senior Regional Medical Liaison, SANOFI
  • Richard Haubrich, M.D., Senior Director, HIV Medical Affairs
  • Sarah Henry, Senior Clinical Project Manager
  • Lance Hill, CEO
  • Nanette Hock, Clinical Research Scientist, Translational Development
  • Brandi Howard, Vice President, Global Clinical Development and Medical Affairs
  • Sarah Jarvis, Associate Principal, Medical Affairs Consulting Lead
  • Gary Kaplan, M.A., Vice President, Medical Affairs Research
  • Shaheen Kaplan, Pharm.D., M.Ed, MBA, Vice President, Medical Affairs
  • Harry Kovelman, M.D., Vice President, Medical Affairs
  • A.W. Lawton, SME, TRANSCELERATE; Lecturer, STANFORD UNIVERSITY
  • Hoyee Leong, Ph.D., Director, Global Medical Information, Oncology, Global Medical Affairs
  • Jay H. Mashburn, Ph.D., R.Ph, PMP, SeniorManager, Medical Affairs—Aesthetic and Corrective
  • Joal Mayor, Pharm.D., Associate Manager, Medical Information
  • Leslie Meltzer, Vice President, Head of Medical Affairs
  • Elizabeth Mena, Associate Director, Medical Sciences
  • Eric Mortenson, Ph.D., Medical Science Liaison, Oncology
  • Poushali Mukherjea, Executive Director, Global Medical Affairs
  • Tony Page, CEO
  • Georgea Pasedis, Pharm.D., Senior Medical Science Liaison
  • Vimal Patel, Senior Director, Customer Engagement
  • Avni Patel, Pharm.D., Associate Director, Global Medical Affairs, Medical Information
  • Joe Petroziello, Senior Director/Head of Scientific Communications
  • Manijeh Pouliot, Pharm.D., BCPS, Regional Medical Liaison, Diabetes Medical Unit
  • Kathleen Ritz, Director, Lead Medical Contact for Europe and Asia-Pacific Regions
  • Chris Robertson, Pharm.D., Director, Medical Affairs Operations and Training
  • Michael Rocco, Director, Business Planning and Communication-Americas
  • Kristin C. Ryan, Pharm.D., Field Director, Medical Science Liaisons
  • John Schenkel, Grant Manager, Global Medical Grants and Research Collaborations
  • Kathryn Shantz, Operations Leader, Medical Evidence & Observational Research
  • Aaron Shaw, RN-BSN, Medical Director, Medical Science Liaison Team
  • Andrew Smith, Ph.D., Senior Director, National Head of MSLs
  • Sara So, M.S., Senior Manager, Scientific Alliances
  • William Soliman, Ph.D., MPhil, M.A., U.S. and Global Medical Director, Rare Diseases, Hepatology/Gastroenterology
  • Colleen Tholen, Associate Manager, Medical Information
  • David M. Tworek, M.S., MBA, Regional Director, Medical Affairs
  • Stéphanie Vézina, Pharm.D., Director,  Medical Customer Interface (MCI)
  • Rebecca Weingard, Director, Medical Affairs
  • Davida J. White, M.D., Global Medical Affairs Director of MSL Training and Development
  • Alan Wright, M.D., MPH, Chief Medical Officer
  • Michael W. Young, Vice President Strategic Accounts

Please fill in your name and email to receive the conference agenda of this event.

September 25, 2017 - Pre-Conference Workshops

September 26, 2017 - Main Conference Day One

September 27, 2017 - Main Conference Day Two

The agenda is available as PDF under downloads at the right side of the page.

Venue

The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.

Medical Affairs Executive Strategy is designed for representatives from pharmaceutical, biotechnology and medical device organizations with responsibilities in the following areas:
  • Medical Affairs/Field Medical Affairs
  • Medical Science/Field Medical Science
  • Clinical/Scientific Affairs
  • Medical Strategy/Communications
  • Key Opinion Leadership/Thought Leadership/Opinion Leader Relationships
  • Research and Development
  • Medical Education
  • Publication Planning
  • Scientific Communication
  • Program Management
  • Quality Assurance
  • Scientific Engagements
  • Medical Science Liaisons


MSL Best Practices is designed for representatives from pharmaceutical, biotechnology and medical device organizations with responsibilities in the following areas:
  • Medical Science Liaisons
  • Medical Science
  • Medical Strategy
  • Scientific Communication
  • Medical Education
  • Key Opinion Leadership/Thought Leadership/Opinion Leader Relationships


Research Collaboration and Investigator-Initiated Trials is designed for representatives from pharmaceutical, biotechnology and medical device organizations with responsibilities in the following areas:
  • Investigator-Initiated Research (IIR)
  • Investigator-Initiated Studies (IIS)
  • Investigator-Initiated Trials (IIT)
  • Investigator-Sponsored Trials (IST)
  • Research Collaborations
  • Medical Affairs/Global Medical Affairs
  • Medical/Clinical Operations
  • Clinical Project Management
  • Clinical Medical Affairs
  • Clinical Trial Monitoring
  • Research Grants
  • Clinical Outcomes and Publications
  • Regulatory Affairs


Medical Information and Call Center Management is designed for representatives from pharmaceutical companies with responsibilities in the following areas:
  • Patient Education
  • Call Center Operations
  • Call Center Management
  • Patient Support
  • Data Management (Call Centers)
  • Call Center Training
  • Call Center Contracting
  • Patient Communication
  • Call Center Compliance
  • Telemedicine
  • Information Management
  • Patient Services
  • Patient Access


Venue

Wyndham San Diego Bayside
1355 N Harbor Dr.
San Diego, CA 92101

To make reservations please call (619)-232-3861 or 1-800-996-3426 and request the negotiated rate for EXL’s Medical Affairs Strategic Summit (MASS) West

To make reservations online Click Here

The group rate is available until September 5, 2017. Please book your room early as rooms available at this rate are limited.
Event details
Organizer : ExL
Event type : Conference
Reference : ASDE-17185